Companies

Alumni
3T Biosciences is solving major bottleneck in the field of immunotherapy - identifying
Alumni
4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy
Alumni
Accelerating the discovery of new drugs through the creation of technologies designed for
Alumni
QuickFire
Challenge Winner
At Ab Initio, we are using a proprietary directed evolution engineering technology to
Alumni
Providing technology platforms that can be tailored and applied to any disease treatable
Abilita Bio’s mission is to discover and develop transformative therapeutics by enabling
Alumni
Achelois’ mission is to develop effective and nontoxic therapeutics to inhibit tumors, and
Acorn Biolabs Inc. is utilizing coming advancements in cellular therapy, tissue
Actavalon is developing small molecule therapeutics capable of restoring p53 tumor
Alumni
Convoy’s technology platform focuses on solving major unmet needs in aesthetics and
Alumni
QuickFire
Challenge Winner
Developing next-generation surgical adhesives based on polyurethane, which permit quick
Alumni
Adicet is developing a novell cell therapy platform.
Advanced Proteome Therapeutics Corporation (APC) is advancing a site-specific protein
Discovery and synthesis of a large portfolio of small molecules that prevent the ability